{"id":375822,"date":"2010-03-01T10:46:37","date_gmt":"2010-03-01T15:46:37","guid":{"rendered":"tag:www.hepatitis-central.com,2010:\/mt\/\/1.782"},"modified":"2010-03-01T10:48:17","modified_gmt":"2010-03-01T15:48:17","slug":"altered-mice-offer-ideal-liver-disease-drug-testing-model","status":"publish","type":"post","link":"https:\/\/mereja.media\/index\/375822","title":{"rendered":"Altered Mice Offer Ideal Liver Disease Drug Testing Model"},"content":{"rendered":"<p>Solving the ongoing challenge of how to test potential liver disease drugs before experimenting on humans, Salk Institute researchers have perfected a system where medications can be tested in mice with mostly human livers.<\/p>\n<p>Mouse With Human Liver: New Model for Treatment of Liver Disease<\/p>\n<p>ScienceDaily (Feb. 23, 2010) &#8212; How do you study-and try to cure in the laboratory-an infection that only humans can get? A team led by Salk Institute researchers does it by generating a mouse with an almost completely human liver. This &#8220;humanized&#8221; mouse is susceptible to human liver infections and responds to human drug treatments, providing a new way to test novel therapies for debilitating human liver diseases and other diseases with liver involvement such as malaria.<\/p>\n<p>Continue reading this entire article:<br \/>\n<a href=\"http:\/\/www.sciencedaily.com\/releases\/2010\/02\/100222182144.htm\">http:\/\/www.sciencedaily.com\/releases\/2010\/02\/100222182144.htm<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Solving the ongoing challenge of how to test potential liver disease drugs before experimenting on humans, Salk Institute researchers have perfected a system where medications can be tested in mice with mostly human livers. Mouse With Human Liver: New Model for Treatment of Liver Disease ScienceDaily (Feb. 23, 2010) &#8212; How do you study-and try [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[7],"tags":[],"class_list":["post-375822","post","type-post","status-publish","format-standard","hentry","category-news"],"_links":{"self":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts\/375822","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/comments?post=375822"}],"version-history":[{"count":0,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts\/375822\/revisions"}],"wp:attachment":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/media?parent=375822"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/categories?post=375822"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/tags?post=375822"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}